Overexpression of immunoglobulin (CD79a) binding protein1 (IGBP-1) in small lung adenocarcinomas and its clinicopathological significance

Pathology International

Volumn 61, Issue 3, 2011, Pages 130-137

  Sakashita, Shingo ^a   Li, Dongping ^a   Nashima, Naohumi ^a   Minami, Yuko ^a   Furuya, Shuuichiro ^b   Morishita, Yukio ^a   Tachibana, Keisei ^a   Sato, Yukio ^a   Noguchi, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

Apoptosis; IGBP 1; Lung adenocarcinoma; PP2Ac

Indexed keywords

BINDING PROTEIN; IMMUNOGLOBULIN BINDING PROTEIN 1; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CARCINOGENESIS; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEIN PHOSPHATASE 2; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79952078921     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02644.x     Document Type: Article

References (34)

1. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75: 191-202.
2. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females. Cancer 1996; 77: 2464-70.
3. Valaitis J, Warren S, Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer 1981; 47: 1042-6.
4. Noguchi M, Morikawa A, Kawasaki M etal. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995; 75: 2844-52.
5. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-17.
6. Hsu LH, Chu NM, Liu CC etal. Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor? Lung Cancer 2009; 66: 262-7.
7. Mountain CF. New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression. Chest 1995; 108: 246-54.
8. Niklinska W, Burzykowski T, Chyczewski L etal. p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland. Eur J Cancer Prev 2000; 9: 81-7.
9. Zhan P, Wang J, Lv XJ etal. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: A systematic review with meta-analysis. J Thorac Oncol 2009; 4: 1094-103.
10. Kanteti R, Yala S, Ferguson MK, Salgia R. MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance. J Environ Pathol Toxicol Oncol 2009; 28: 89-98.
11. Anami Y, Iijima T, Suzuki K etal. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thorac Oncol 2009; 4: 951-8.
12. Ishii A, Suzuki M, Satomi K etal. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression. Pathol Int 2009; 59: 623-30.
13. Uchihara T, Okubo C, Tanaka R etal. Neuronatin expression and its clinicopathological significance in pulmonary non-small cell carcinoma. J Thorac Oncol 2007; 2: 796-801.
14. Tanaka R, Ishiyama T, Uchihara T etal. Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma. Cancer 2006; 106: 648-53.
15. Inui S, Kuwahara K, Mizutani J etal. Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. J Immunol 1995; 154: 2714-23.
16. Chuang E, Fisher TS, Morgan RW etal. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 2000; 13: 313-22.
17. Everett AD, Brautigan DL. Developmental expression of alpha4 protein phosphatase regulatory subunit in tissues affected by Opitz syndrome. Dev Dyn 2002; 224: 461-4.
18. Murata K, Wu J, Brautigan DL. B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A 1997; 94: 10624-9.
19. Chen J, Peterson RT, Schreiber SL. Alpha 4 associates with protein phosphatases 2A, 4, and 6. Biochem Biophys Res Commun 1998; 247: 827-32.
20. Lechward K, Awotunde OS, Swiatek W, Muszynska G. Protein phosphatase 2A: Variety of forms and diversity of functions. Acta Biochim Pol 2001; 48: 921-33.
21. Sontag E. Protein phosphatase 2A: The Trojan Horse of cellular signaling. Cell Signal 2001; 13: 7-16.
22. Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol 2000; 60: 1225-35.
23. Mumby MC, Walter G. Protein serine/threonine phosphatases: Structure, regulation, and functions in cell growth. Physiol Rev 1993; 73: 673-99.
24. Wera S, Hemmings BA. Serine/threonine protein phosphatases. Biochem J 1995; 311(Pt 1): 17-29.
25. Ruediger R, Roeckel D, Fait J, Bergqvist A, Magnusson G, Walter G. Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol 1992; 12: 4872-82.
26. Janssens V, Goris J. Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001; 353: 417-39.
27. Turowski P, Favre B, Campbell KS, Lamb NJ, Hemmings BA. Modulation of the enzymatic properties of protein phosphatase 2A catalytic subunit by the recombinant 65-kDa regulatory subunit PR65alpha. Eur J Biochem 1997; 248: 200-8.
28. Agostinis P, Derua R, Sarno S, Goris J, Merlevede W. Specificity of the polycation-stimulated (type-2A) and ATP, Mg-dependent (type-1) protein phosphatases toward substrates phosphorylated by P34cdc2 kinase. Eur J Biochem 1992; 205: 241-8.
29. Inui S, Sanjo H, Maeda K, Yamamoto H, Miyamoto E, Sakaguchi N. Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 1998; 92: 539-46.
30. Kong M, Fox CJ, Mu J etal. The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science 2004; 306: 695-8.
31. Travis WDBE, Muller-Hermelink KH, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
32. Onda M, Inui S, Maeda K, Suzuki M, Takahashi E, Sakaguchi N. Expression and chromosomal localization of the human alpha 4/IGBP1 gene, the structure of which is closely related to the yeast TAP42 protein of the rapamycin-sensitive signal transduction pathway. Genomics 1997; 46: 373-8.
33. Xue C, Heller F, Johns RA, Everett AD. Developmental expression and localization of the catalytic subunit of protein phosphatase 2A in rat lung. Dev Dyn 1998; 211: 1-10.
34. Fielhaber JA, Han YS, Tan J etal. Inactivation of mammalian target of rapamycin increases STAT1 nuclear content and transcriptional activity in alpha4- and protein phosphatase 2A-dependent fashion. J Biol Chem 2009; 284: 24341-53.